Company: SMNR
Filing Date: 2025-08-12
Form Type: S-4/A
Source: 0001193125-25-178821
Chunk: 679

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-12
Form: S-4/A
Chunk 679
---
 New Semnur consents in writing to the selection of an alternative forum, to the fullest extent permitted by law, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. Although New Semnur believes these provisions benefit the company by providing increased consistency in the application of applicable law in the types of lawsuits to which they apply, the provisions may have the effect of discouraging lawsuits against New Semnur’s directors and officers. The enforceability of similar choice of forum provisions in other companies’ certificates of incorporation has been challenged in legal proceedings and there is uncertainty as to whether a court would enforce such provisions. In addition, investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. It is possible that, in connection with any applicable action brought against New Semnur, a court could find the choice of forum provisions contained in the Proposed Charter to be inapplicable or unenforceable in such action. New Semnur may incur additional costs associated with resolving such action in other jurisdictions, which could harm the business, operating results and financial condition of New Semnur. Any person or entity purchasing or otherwise acquiring any interest in shares of New Semnur’s capital stock shall be deemed to have notice of and consented to the forum provisions in the Proposed Charter. Limitation of Liability and Indemnification of Directors and Officers The Proposed Charter and the Proposed Bylaws, which will become effective immediately prior to the consummation of the Business Combination, will contain provisions that limit the liability of New Semnur’s directors and officers for monetary damages to the fullest extent permitted by the DGCL. Consequently, New Semnur’s directors and officers will not be personally liable to New Semnur or its stockholders for monetary damages for any breach of fiduciary duties as directors or officers, as applicable, except liability for the following:

| • |     | any breach of their duty of loyalty to New Semnur or its stockholders; |

| • |     | acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; |

| • |     | unlawful payments of dividends or unlawful stock repurchases or redemptions in violation of the DGCL; |

| • |     | any transaction from which the director or the officer derived an improper personal benefit; or |

| • |     | with respect to any officer, any action by or in the